Gut bacteria may lead to new IBD treatment

06/1/2008 | Reuters

Harvard researchers are investigating whether a complex sugar molecule created naturally by bacteria in the human gut might be the basis of a new type of treatment for inflammatory bowel disease. In mice studies, the sugar molecule changed the body's immune response and reduced inflammation.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI
Vice President of Finance
Urban Health Plan, Inc.
Bronx, NY
Director of Payor/Provider Contracting
U.S. Medical Management
Tryo, MI